MARQUETTE, Mich. (WLUC) - An area doctor, right in Marquette, is part of a multinational therapy trial. This is the second stage of the trial to assess chelation therapy. The trial is a 40-week intravenous therapy that removes heavy metals from patients.
Heavy metals collect in the body from number of different sources including tainted water, like in Flint, and even simply from the air next to roads. Those metals can cause abdominal pain, dysfunction in the central nervous system and heart problems.
“For years, doctors that do chelation have known that it seems to have a benefit on the circulatory system in their patients,” said Dr. Scott Doughty, MD, of U.P. Holistic Medicine.
Doctors can use the technique to remove toxins that stand in the way of the body healing itself.
“It’s always been about removing things that shouldn't be in the body that are metallic,” Doughty said.
The therapy itself has been around for 80 years, starting after World War I to detox soldiers. The therapy using ethylene diamine tetra-acetic acid (EDTA) works by stripping away all metals in the body, then replacing the useful metals with supplements. Through case studies and research, the therapies have developed over the years.
“The evolution in technique has been with safety and use of materials that aren't toxic themselves,” Doughty said.
The work among doctors who use chelation therapy to treat patients, resulted in this study sponsored by the National Institute of Health.
“This is a study or a research trial that is based at the NIH in terms of its funding source,” Doughty said. “…We don’t say chelation is good for what ails ya, but most of the degenerative conditions, whether it's high blood pressure or heart disease, there's been benefit with chelation in all of those”
For more information about the study and the clinic conducting the trials, visit the websites in our related links section.